TLR4 Inhibition Attenuates Vascular Remodeling in A Mouse Model of Chronic Kidney Disease

Area of Science:

• Cardiovascular Biology
• Nephrology
• Immunology

Background:

• Chronic kidney disease (CKD) is associated with accelerated vascular remodeling, including medial thickening and fibrosis.
• The precise molecular mechanisms underlying CKD-driven vascular remodeling are not fully understood.

Purpose of the Study:

• To investigate the role of toll-like receptor 4 (TLR4) in vascular remodeling associated with CKD.
• To evaluate the therapeutic potential of TLR4 inhibition in a mouse model of CKD.

Main Methods:

• A 5/6 nephrectomy mouse model was used to induce CKD.
• TLR4 signaling was inhibited using TAK-242, a specific small-molecule inhibitor.
• Vascular remodeling, macrophage accumulation, cell proliferation, and inflammatory markers were assessed.

Main Results:

• TLR4 blockade significantly reduced aortic medial thickening and perivascular fibrosis, independent of blood pressure.
• Inhibition of TLR4 decreased macrophage accumulation and proliferation of cells in the aorta.
• TLR4 blockade suppressed Interleukin-6 (IL-6) mRNA expression, and reduced CKD serum-induced IL-6 expression and vascular smooth muscle cell growth.

Conclusions:

• TLR4-mediated sterile inflammation contributes to vascular remodeling in CKD.
• Targeting TLR4 signaling presents a potential therapeutic strategy to mitigate cardiovascular complications in CKD.